Porter Bayne, as Cofounder turned Adviser on Operations, Tech, and Patient Relations at SeekMD, is at the forefront of revolutionizing pediatric eye care through innovative technology and a patient-centric approach. With a unique blend of skills in software development, user experience design, and strategic operations,...
Porter Bayne, as Cofounder turned Adviser on Operations, Tech, and Patient Relations at SeekMD, is at the forefront of revolutionizing pediatric eye care through innovative technology and a patient-centric approach. With a unique blend of skills in software development, user experience design, and strategic operations, Porter has played a pivotal role in establishing SeekMD as a leader in the field. His expertise is particularly evident in the development of a custom, dynamic Electronic Health Record (EHR) system tailored specifically for pediatric ophthalmology. This groundbreaking tool not only streamlines data entry but also enhances the accuracy of medical records, significantly reducing the potential for errors in a clinical environment where precision is paramount.
Porter’s commitment to empathy and patient empowerment is reflected in every aspect of SeekMD's operations. By fostering a culture that prioritizes the needs of young patients and their families, he ensures that the clinic remains aligned with evidence-based practices while also being responsive to the emotional and psychological needs of its clientele. His multifaceted background—ranging from coding and design to fundraising and team building—enables him to approach challenges from various angles, making him an invaluable asset to the SeekMD team.
In addition to his technical prowess, Porter’s inquisitive nature drives continuous improvement within the organization. He actively engages with team members across disciplines, asking the "annoying questions" that lead to deeper insights and better solutions. As SeekMD continues to grow, Porter’s vision and leadership will undoubtedly shape the future of pediatric eye care, ensuring that it remains both innovative and compassionate.
